Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'Allotment of Equity Shares under ESOP Plan 2022'.
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jagsonpal Pharmaceuticals has allotted 66,000 equity shares (face value Rs. 2 each) to eligible employees under its Employee Stock Option Plan 2022, upon exercise of vested stock options. The exercise prices were Rs. 94 for 58,125 shares, Rs. 113.60 for 6,335 shares, and Rs. 115.60 for 1,540 shares. As a result, the paid-up share capital has increased marginally from Rs. 13.31 crore to Rs. 13.33 crore, with total issued shares rising from 6,65,65,254 to 6,66,31,254. The new shares rank pari-passu with existing equity shares. The dilution is about 0.1% of the existing share base, making this a routine, low-impact event.
This is a routine ESOP allotment causing negligible dilution (less than 0.1%) for existing shareholders. No material impact on share price or shareholder value is expected.